Yanagie H - Search Results

1

Inhibition of human pancreatic cancer growth by the adenovirus-mediated introduction of a novel growth suppressing gene, tob, in vitro.

Yanagie H, Sumimoto H, Nonaka Y, Matsuda S, Hirose I, Hanada S, Sugiyama H, Mikamo S, Takeda Y, Yoshizaki I, Nakazawa K, Tani K, Yamamoto T, Asano S, Eriguchi M, Muto T. Yanagie H, et al. Adv Exp Med Biol. 1998;451:91-6. doi: 10.1007/978-1-4615-5357-1_15. Adv Exp Med Biol. 1998. PMID: 10026856 No abstract available.

2

Tumor growth suppression by adenovirus-mediated introduction of a cell-growth-suppressing gene tob in a pancreatic cancer model.

Yanagie H, Tanabe T, Sumimoto H, Sugiyama H, Matsuda S, Nonaka Y, Ogiwara N, Sasaki K, Tani K, Takamoto S, Takahashi H, Eriguchi M. Yanagie H, et al. Biomed Pharmacother. 2009 May;63(4):275-86. doi: 10.1016/j.biopha.2008.04.010. Epub 2008 Jun 18. Biomed Pharmacother. 2009. PMID: 18657378

3

Inhibition of growth of human breast cancer cells in culture by neutron capture using liposomes containing 10B.

Yanagië H, Kobayashi H, Takeda Y, Yoshizaki I, Nonaka Y, Naka S, Nojiri A, Shinnkawa H, Furuya Y, Niwa H, Ariki K, Yasuhara H, Eriguchi M. Yanagië H, et al. Biomed Pharmacother. 2002 Mar;56(2):93-9. doi: 10.1016/s0753-3322(01)00161-5. Biomed Pharmacother. 2002. PMID: 12000141

4

Bcl-2, Bcl-xL and c-FLIP(L) potentially regulate the susceptibility of human peripheral blood monocyte-derived dendritic cells to cell death at different developmental stages.

Hasebe H, Sato K, Yanagie H, Takeda Y, Nonaka Y, Takahashi TA, Eriguchi M, Nagawa H. Hasebe H, et al. Among authors: yanagie h. Biomed Pharmacother. 2002 May;56(3):144-51. doi: 10.1016/s0753-3322(02)00164-6. Biomed Pharmacother. 2002. PMID: 12046686

5

[Gene therapy for liver metastasis of colon cancer].

Yanagie H, Eriguchi M. Yanagie H, et al. Nihon Rinsho. 2005 Dec;63 Suppl 12:537-43. Nihon Rinsho. 2005. PMID: 16416849 Review. Japanese. No abstract available.

6

Establishment of a natural suppressor cell line producing soluble suppressor factor other than transforming growth factor-beta.

Yanagië H, Sugiyama H, Sekiguchi M. Yanagië H, et al. Immunol Cell Biol. 1995 Aug;73(4):333-9. doi: 10.1038/icb.1995.51. Immunol Cell Biol. 1995. PMID: 7493770

7

Inhibition of human pancreatic cancer growth in nude mice by boron neutron capture therapy.

Yanagië H, Tomita T, Kobayashi H, Fujii Y, Nonaka Y, Saegusa Y, Hasumi K, Eriguchi M, Kobayashi T, Ono K. Yanagië H, et al. Br J Cancer. 1997;75(5):660-5. doi: 10.1038/bjc.1997.118. Br J Cancer. 1997. PMID: 9043021 Free PMC article.

8

Regulation of mouse immuno-responses by a natural suppressor cell clone from bone marrow.

Yanagië H, Chen Z, Takeda Y, Sugiyama H, Sekiguchi M, Eriguchi M. Yanagië H, et al. Res Exp Med (Berl). 1997;197(3):165-75. doi: 10.1007/s004330050066. Res Exp Med (Berl). 1997. PMID: 9406284

9

Surgery in patients with HIV infection: indications and outcome.

Eriguchi M, Takeda Y, Yoshizaki I, Akiyama N, Yanagie H, Fujii Y. Eriguchi M, et al. Among authors: yanagie h. Biomed Pharmacother. 1997;51(10):474-9. doi: 10.1016/s0753-3322(97)82329-3. Biomed Pharmacother. 1997. PMID: 9863509

10

Docetaxel alone or orally combined with 5-fluorouracil and its derivatives: effects on mouse mammary tumor cell line MM2 in vitro and in vivo.

Takeda Y, Yoshizaki I, Nonaka Y, Yanagie H, Matsuzawa A, Eriguchi M. Takeda Y, et al. Among authors: yanagie h. Anticancer Drugs. 2001 Sep;12(8):691-8. doi: 10.1097/00001813-200109000-00008. Anticancer Drugs. 2001. PMID: 11604557

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters